Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Genprex Inc (GB:0A8I)
LSE:0A8I
Genprex (0A8I) Stock Price & Analysis
0 Followers
0A8I Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.76 - $2.62
Previous Close$0.88
Volume950.00
Average Volume (3M)2.62K
Market Cap
$46.26M
Enterprise Value$28.18M
Total Cash (Recent Filing)$18.08M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)N/A
Beta1.72
Next Earnings
Aug 13, 2019EPS Estimate
-$0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,203
30 Day Avg. Volume2,624
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.18
Enterprise Value/Ebitda-3.19
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Genprex News
0A8I FAQ
What was Genprex Inc’s price range in the past 12 months?
Genprex Inc lowest stock price was $0.76 and its highest was $2.62 in the past 12 months.
What is Genprex Inc’s market cap?
Currently, no data Available
When is Genprex Inc’s upcoming earnings report date?
Genprex Inc’s upcoming earnings report date is Aug 13, 2019 which is 1385 days ago.
How were Genprex Inc’s earnings last quarter?
Genprex Inc released its earnings results on May 15, 2019. The company reported -$0.141 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.141.
Is Genprex Inc overvalued?
According to Wall Street analysts Genprex Inc’s price is currently Overvalued.
Does Genprex Inc pay dividends?
Genprex Inc does not currently pay dividends.
What is Genprex Inc’s EPS estimate?
Genprex Inc’s EPS estimate is -$0.21.
How many shares outstanding does Genprex Inc have?
Currently, no data Available
What happened to Genprex Inc’s price movement after its last earnings report?
Genprex Inc reported an EPS of -$0.141 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Genprex Inc?
Currently, no hedge funds are holding shares in GB:0A8I
---
Genprex Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
GB:0A8I Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $41.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.26%
12-Months-Change
Fundamentals
Return on Equity
-98.08%
Trailing 12-Months
Asset Growth
-40.83%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Genprex Inc
Genprex, Inc. is a clinical stage gene therapy company, which engages in the development of novel proprietary technology platform for the treatment of cancer. It develops the Oncoprex immunogene therapy which targets the non-small cell lung cancer and other solid tumors. The company was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.
---
Cardiff Oncology
―
Passage Bio
―
Bioqual
―
Abeona Therapeutics
―
Assembly Biosciences
―
---